Fresenius Medical Care AG (FMS) Non Operating Interest Expenses (2009 - 2026)

On a TTM basis, Fresenius Medical Care AG's Non Operating Interest Expenses came in at $446.7 million as of Jun 30, 2026, up 4.7% year-over-year; for the year ended Dec 31, 2025, it was $434.31 million, down 1.4% from the prior year.

• Annual Non Operating Interest Expenses has a five-year compound annual growth rate of -1.5% (years ended Dec 2020 to Dec 2025).
• Across earlier years, Non Operating Interest Expenses came in at $440.56 million in the year ended Dec 31, 2024 (-4.1%), $459.34 million in the year ended Dec 31, 2023 (+25.0%), $367.43 million in the year ended Dec 31, 2022 (-12.2%) and $418.45 million in the year ended Dec 31, 2021 (-10.6%).
• Quarterly Non Operating Interest Expenses has ranged from $89.98 million in the quarter ended Jun 30, 2022 to $123.94 million in the quarter ended Sep 30, 2023 over the past five years.
• On a year-over-year basis, Non Operating Interest Expenses has increased for three consecutive quarters, with an average decline of 2.0% over the last eight quarters.
• Peak year-over-year performance for Non Operating Interest Expenses in the last five years was growth of 32.8% in the quarter ended Sep 30, 2023, against a decline of 15.2% in the quarter ended Mar 31, 2022 at the low end.
• Per Business Quant, the preceding three quarters came in at $109.23 million (quarter ended Mar 31, 2026), $115.24 million (quarter ended Dec 31, 2025) and $108.83 million (quarter ended Sep 30, 2025).